Colombia vs North Macedonia: Survival to age 65, male
Colombia
82.0%
in 2024
North Macedonia
82.2%
in 2024
Colombia rank
67th
North Macedonia rank
66th
Survival to age 65, male over time
- Colombia
- North Macedonia
How they compare
North Macedonia currently reports 82.2% against 82.0% in Colombia, a difference of 0.2%.
The two have swapped places 4 times across 65 shared years of data; in 1960 it was North Macedonia ahead.
Colombia ranks 67th and North Macedonia ranks 66th of 218 countries.
North Macedonia has averaged higher in every one of the 7 decades both report.
Head to head by decade
| Decade | Colombia | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 53.4% | 64.0% | 10.6% | North Macedonia |
| 1970s | 59.2% | 68.4% | 9.2% | North Macedonia |
| 1980s | 62.3% | 70.9% | 8.6% | North Macedonia |
| 1990s | 64.7% | 71.5% | 6.7% | North Macedonia |
| 2000s | 71.9% | 74.3% | 2.4% | North Macedonia |
| 2010s | 78.7% | 78.9% | 0.2% | North Macedonia |
| 2020s | 77.9% | 78.9% | 1.0% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Colombia or North Macedonia?
- North Macedonia, at 82.2% against 82.0% in Colombia as of 2024.
- What is the difference in survival to age 65, male between Colombia and North Macedonia?
- 0.2%, with North Macedonia ahead.
- How many years of comparable data are there for Colombia and North Macedonia?
- 65 years are reported by both, from 1960 to 2024.
- How do Colombia and North Macedonia rank globally for survival to age 65, male?
- Colombia ranks 67th and North Macedonia ranks 66th of 218 countries.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.